|
15
|
68
|
9yipA |
Crystal structure of human il-8 in a large unit cell |
|
31
|
125
|
9vwqA |
Crystal structure of nanobody nb3.30 |
|
26
|
117
|
9vwoB |
Human osm in complex with nb3.30 |
|
56
|
183
|
9vwpA |
Human osm in complex with nb3.43 |
|
60
|
183
|
9vwoA |
Human osm in complex with nb3.30 |
|
24
|
114
|
9vwpC |
Human osm in complex with nb3.43 |
|
53
|
150
|
9xnlA |
Grass carp ifnd |
|
21
|
112
|
13fjA |
Tgfb1 in complex with nis793 fab |
|
44
|
224
|
13fjH |
Tgfb1 in complex with nis793 fab |
|
48
|
213
|
13fjL |
Tgfb1 in complex with nis793 fab |
|
19
|
83
|
21ngA |
Structure of ifp35 nid domain dimer form |
|
12
|
86
|
21otA |
Structure of ifp35 nid domain octamer form |
|
19
|
89
|
21nhA |
Structure of nmi nid domain dimer form |
|
0
|
24
|
9mxfA |
Grn-p4a isomer 1, granulin |
|
0
|
24
|
9mxgA |
Grn-p4a mutant, granulin |
|
0
|
24
|
9mxeA |
Grn-p4a isomer 2, granulin |
|
51
|
219
|
9sg2L |
Ixekizumab fab in complex with human il-17a |
|
20
|
109
|
9sg0L |
Cjm112 fv in complex with human il-17a |
|
52
|
213
|
9sghB |
Bimekizumab fab in complex with human interleukin-17a |
|
26
|
111
|
9sfxA |
Secukinumab fv in complex with human il-17a |
|
49
|
226
|
9sghA |
Bimekizumab fab in complex with human interleukin-17a |
|
41
|
219
|
9sg2H |
Ixekizumab fab in complex with human il-17a |
|
10
|
112
|
9sg2A |
Ixekizumab fab in complex with human il-17a |
|
10
|
108
|
9sg0A |
Cjm112 fv in complex with human il-17a |
|
11
|
115
|
9sghI |
Bimekizumab fab in complex with human interleukin-17a |
|
32
|
128
|
9sfxB |
Secukinumab fv in complex with human il-17a |
|
20
|
105
|
9sfxL |
Secukinumab fv in complex with human il-17a |
|
29
|
117
|
9sfxH |
Secukinumab fv in complex with human il-17a |
|
26
|
116
|
9sg0H |
Cjm112 fv in complex with human il-17a |
|
12
|
111
|
9sfxC |
Secukinumab fv in complex with human il-17a |
|
35
|
117
|
9yyaA |
Macrophage migration inhibitory factor 1 from necator americanus |
|
30
|
122
|
9vjjH |
Crystal structure of human latent tgf-beta1 in complex with sof10 |
|
58
|
354
|
9vjjA |
Crystal structure of human latent tgf-beta1 in complex with sof10 |
|
22
|
107
|
9vjjL |
Crystal structure of human latent tgf-beta1 in complex with sof10 |
|
12
|
65
|
9e6pA |
Structure of a mouse kc dimeric mutant |
|
11
|
65
|
9e6oA |
Structure of a mouse kc filament |
|
35
|
117
|
9o3uAAA |
Crystal structure of k109a variant of d-dopachrome tautomerase (d-dt) |
|
34
|
117
|
9o3sAAA |
Crystal structure of r36a variant of d-dopachrome tautomerase (d-dt) |
|
35
|
117
|
9o3tAAA |
Crystal structure of s63a variant of d-dopachrome tautomerase (d-dt) |
|
34
|
117
|
9o3rAAA |
Crystal structure of i64a variant of d-dopachrome tautomerase (d-dt) |
|
46
|
360
|
21twA |
Cryo-em structure of tnf-alpha in complex with two anti-tnf-alpha nanobodies, tnf30, derived from the tnf-alpha inhibitor ozoralizumab (ozr) |
|
41
|
360
|
21tvA |
Cryo-em structure of the tnf-alpha-ozoralizumab (ozr)-hsa complex |
|
169
|
582
|
21tvE |
Cryo-em structure of the tnf-alpha-ozoralizumab (ozr)-hsa complex |
|
15
|
148
|
21tvB |
Cryo-em structure of the tnf-alpha-ozoralizumab (ozr)-hsa complex |
|
20
|
148
|
21twB |
Cryo-em structure of tnf-alpha in complex with two anti-tnf-alpha nanobodies, tnf30, derived from the tnf-alpha inhibitor ozoralizumab (ozr) |
|
36
|
118
|
9nt1A |
Crystal structure of lingulodinium polyedra mif (lpmif) |
|
12
|
110
|
9sr8A |
Crystal structure of il-17a in complex with compound 22 |
|
14
|
112
|
9sqiA |
Crystal structure of il-17a in complex with compound 21 |
|
15
|
114
|
9sqxA |
Crystal structure of il-17a in complex with compound 19 |
|
31
|
114
|
9yi5A |
Macrophage migration inhibitory factor 2 from heligmosomoides polygyrus |
